(Q46987602)

27 December 2017

title

Collagen type VIII expression in human diabetic nephropathy (English)

1 reference

27 December 2017

author name string

Gerth J

1

1 reference

27 December 2017

Cohen CD

2

1 reference

27 December 2017

Hopfer U

3

1 reference

27 December 2017

Lindenmeyer MT

4

1 reference

27 December 2017

Sommer M

5

1 reference

27 December 2017

Gröne HJ

6

1 reference

27 December 2017

Wolf G

7

1 reference

27 December 2017

publication date

1 October 2007

1 reference

27 December 2017

European Journal of Clinical Investigation

published in

1 reference

27 December 2017

volume

37

1 reference

27 December 2017

issue

10

1 reference

27 December 2017

page(s)

767-773

1 reference

27 December 2017

Pathogenetic mechanisms of diabetic nephropathy

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01864.X

New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01864.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01864.X

Type VIII collagen has a restricted distribution in specialized extracellular matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01864.X

Type VIII collagen stimulates smooth muscle cell migration and matrix metalloproteinase synthesis after arterial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01864.X

Basement membrane abnormalities in human eyes with diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01864.X

Validation of endogenous controls for gene expression analysis in microdissected human renal biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01864.X

Mast cells and type VIII collagen in human diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01864.X

Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01864.X

Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01864.X

Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01864.X

Epithelial-mesenchymal transition and its implications for fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01864.X

A stereological study of the renal glomerular vasculature in the db/db mouse model of diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01864.X

Endogenous inhibitors of angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01864.X

10.1111/J.1365-2362.2007.01864.X

21 January 2018

Identifiers

DOI

1 reference

27 December 2017

PubMed ID

17888087

1 reference

27 December 2017